HIMX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Himax Technologies is not a good buy right now for a beginner long-term investor with $50,000-$100,000 available. The stock is showing short-term technical strength, but the fundamental picture is weak and analyst sentiment is negative. Since the user is impatient and does not want to wait for a better entry, my direct view is to avoid buying now and hold off until fundamentals improve or the price becomes more attractive.
HIMX is in a short-term uptrend: SMA_5 is above SMA_20 and SMA_200, MACD histogram is positive at 0.0591, and RSI_6 at 62.41 suggests moderate momentum without being overbought. Pre-market price is 11.91, above the current price of 11.75, indicating strength before the open. Key levels to watch are pivot 11.425, resistance 12.005, and support 10.844. The trend is constructive technically, but the MACD histogram is positively contracting, so upside momentum may be slowing.
["Semiconductor sector has been strong, up 68.1% over the past six months.", "Technical trend is bullish with SMA_5 > SMA_20 > SMA_200.", "Options positioning is strongly call-biased, suggesting bullish trading sentiment.", "Pre-market price is up 1.36%, showing early demand."]
["Morgan Stanley downgraded HIMX to Equal Weight from Overweight with an unchanged $8 target.", "Analyst commentary points to weaker computer, smartphone, and auto demand plus gross margin pressure.", "2025/Q4 revenue fell 14.39% YoY and net income dropped 74.25% YoY.", "EPS declined 71.43% YoY and gross margin also slipped.", "Himax has been cited as potentially needing capital due to a high net-debt-to-EBITDA ratio of 6x.", "No meaningful insider, hedge fund, or congress buying support was reported."]
In 2025/Q4, Himax's revenue fell to 203.1M, down 14.39% YoY. Net income dropped to 6.34M, down 74.25% YoY, and EPS fell to 0.02, down 71.43% YoY. Gross margin was 30.38%, slightly down 0.26% YoY. The latest quarter shows clear deterioration in growth and profitability, which is a weak long-term signal.
Recent analyst sentiment turned negative: Morgan Stanley downgraded Himax to Equal Weight from Overweight and kept the price target at $8. The analyst cited weaker end-market demand, gross margin pressure, and limited new growth drivers. This is a clear bearish shift in the Wall Street pros view. There is no evidence of influential insider, hedge fund, or congress buying to offset that view.
